BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 26647726)

  • 1. Liver epithelial cells inhibit proliferation and invasiveness of hepatoma cells.
    Jeng KS; Jeng CJ; Jeng WJ; Sheen IS; Li SY; Hung ZH; Hsiau HI; Yu MC; Chang CF
    Oncol Rep; 2016 Mar; 35(3):1622-8. PubMed ID: 26647726
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tropism of liver epithelial cells toward hepatocellular carcinoma in vitro and in vivo with altering gene expression of cancer stem cells.
    Jeng KS; Jeng CJ; Jeng WJ; Sheen IS; Li SY; Lu SJ; Chang CF
    Am J Surg; 2018 Apr; 215(4):735-743. PubMed ID: 29246405
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA-375 targets AEG-1 in hepatocellular carcinoma and suppresses liver cancer cell growth in vitro and in vivo.
    He XX; Chang Y; Meng FY; Wang MY; Xie QH; Tang F; Li PY; Song YH; Lin JS
    Oncogene; 2012 Jul; 31(28):3357-69. PubMed ID: 22056881
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gankyrin-mediated dedifferentiation facilitates the tumorigenicity of rat hepatocytes and hepatoma cells.
    Sun W; Ding J; Wu K; Ning BF; Wen W; Sun HY; Han T; Huang L; Dong LW; Yang W; Deng X; Li Z; Wu MC; Feng GS; Xie WF; Wang HY
    Hepatology; 2011 Oct; 54(4):1259-72. PubMed ID: 21735473
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor-associated macrophages promote cancer stem cell-like properties via transforming growth factor-beta1-induced epithelial-mesenchymal transition in hepatocellular carcinoma.
    Fan QM; Jing YY; Yu GF; Kou XR; Ye F; Gao L; Li R; Zhao QD; Yang Y; Lu ZH; Wei LX
    Cancer Lett; 2014 Oct; 352(2):160-8. PubMed ID: 24892648
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of bone marrow-derived mesenchymal stromal cells on hepatoma.
    Abd-Allah SH; Shalaby SM; El-Shal AS; Elkader EA; Hussein S; Emam E; Mazen NF; El Kateb M; Atfy M
    Cytotherapy; 2014 Sep; 16(9):1197-206. PubMed ID: 24985939
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of β -catenin siRNA on proliferation and apoptosis of hepatoma cell line SMMC-7721 and HepG-2.
    Liyan W; Xun S; Xiangwei M
    Hepatogastroenterology; 2011; 58(110-111):1757-64. PubMed ID: 22086699
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overexpression of syntenin enhances hepatoma cell proliferation and invasion: potential roles in human hepatoma.
    Liu X; Zhang X; Lv Y; Xiang J; Shi J
    Oncol Rep; 2014 Dec; 32(6):2810-6. PubMed ID: 25242117
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lentiviral-mediated short hairpin RNA silencing of APE1 suppresses hepatocellular carcinoma proliferation and migration: A potential therapeutic target for hepatoma treatment.
    Zheng ZH; Du W; Li YJ; Gao MQ; Huang AM; Liu JF
    Oncol Rep; 2015 Jul; 34(1):95-102. PubMed ID: 25976295
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ultrasound-targeted microbubble destruction-mediated downregulation of CD133 inhibits epithelial-mesenchymal transition, stemness and migratory ability of liver cancer stem cells.
    Liu YM; Li XF; Liu H; Wu XL
    Oncol Rep; 2015 Dec; 34(6):2977-86. PubMed ID: 26370320
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Defeating EpCAM(+) liver cancer stem cells by targeting chromatin remodeling enzyme CHD4 in human hepatocellular carcinoma.
    Nio K; Yamashita T; Okada H; Kondo M; Hayashi T; Hara Y; Nomura Y; Zeng SS; Yoshida M; Hayashi T; Sunagozaka H; Oishi N; Honda M; Kaneko S
    J Hepatol; 2015 Nov; 63(5):1164-72. PubMed ID: 26095183
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suppressive effects of microRNA-16 on the proliferation, invasion and metastasis of hepatocellular carcinoma cells.
    Wu WL; Wang WY; Yao WQ; Li GD
    Int J Mol Med; 2015 Dec; 36(6):1713-9. PubMed ID: 26499886
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatoma-targeted gene delivery using a tumor cell-specific gene regulation system combined with a human liver cell-specific bionanocapsule.
    Kang JH; Oishi J; Kim JH; Ijuin M; Toita R; Jun B; Asai D; Mori T; Niidome T; Tanizawa K; Kuroda S; Katayama Y
    Nanomedicine; 2010 Aug; 6(4):583-9. PubMed ID: 20138242
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loss of expression of Kruppel-like factor 6 in primary hepatocellular carcinoma and hepatoma cell lines.
    Wang SP; Zhou HJ; Chen XP; Ren GY; Ruan XX; Zhang Y; Zhang RL; Chen J
    J Exp Clin Cancer Res; 2007 Mar; 26(1):117-24. PubMed ID: 17550140
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of tumorigenesis and metastasis of hepatocellular carcinoma tumor endothelial cells by microRNA-3178 and underlying mechanism.
    Li W; Shen S; Wu S; Chen Z; Hu C; Yan R
    Biochem Biophys Res Commun; 2015 Aug; 464(3):881-7. PubMed ID: 26182877
    [TBL] [Abstract][Full Text] [Related]  

  • 16. microRNA-150 inhibits human CD133-positive liver cancer stem cells through negative regulation of the transcription factor c-Myb.
    Zhang J; Luo N; Luo Y; Peng Z; Zhang T; Li S
    Int J Oncol; 2012 Mar; 40(3):747-56. PubMed ID: 22025269
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The tumor-suppressor gene LZTS1 suppresses hepatocellular carcinoma proliferation by impairing PI3K/Akt pathway.
    He Y; Liu X
    Biomed Pharmacother; 2015 Dec; 76():141-6. PubMed ID: 26653561
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor-targeted gene therapy using Adv-AFP-HRPC/IAA prodrug system suppresses growth of hepatoma xenografted in mice.
    Dai M; Liu J; Chen DE; Rao Y; Tang ZJ; Ho WZ; Dong CY
    Cancer Gene Ther; 2012 Feb; 19(2):77-83. PubMed ID: 21959967
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antitumoural hydroxyapatite nanoparticles-mediated hepatoma-targeted trans-arterial embolization gene therapy: in vitro and in vivo studies.
    Li G; Ye L; Pan J; Long M; Zhao Z; Yang H; Tian J; Wen Y; Dong S; Guan J; Luo B
    Liver Int; 2012 Jul; 32(6):998-1007. PubMed ID: 22340582
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Downregulation of PRRX1 Confers Cancer Stem Cell-Like Properties and Predicts Poor Prognosis in Hepatocellular Carcinoma.
    Hirata H; Sugimachi K; Takahashi Y; Ueda M; Sakimura S; Uchi R; Kurashige J; Takano Y; Nanbara S; Komatsu H; Saito T; Shinden Y; Iguchi T; Eguchi H; Atsumi K; Sakamoto K; Doi T; Hirakawa M; Honda H; Mimori K
    Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1402-9. PubMed ID: 25404478
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.